Antares Pharma, Inc.: 10-Q filed 2013-05-08
What Antares Pharma, Inc. reported in its quarterly report filed 2013-05-08 (fiscal Q1 2013): 38 published measures, 78 facts as tagged in accession 0001193125-13-207601.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-05-08
- Fiscal period
- fiscal Q1 2013
- Accession
- 0001193125-13-207601 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Antares Pharma, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 90,882,647 | USD | |
| At 2012-12-31 | 95,526,610 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 7,309,842 | USD | |
| At 2012-12-31 | 8,976,018 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 83,572,805 | USD | |
| At 2012-12-31 | 86,550,592 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 38,126,055 | USD | |
| At 2012-12-31 | 52,097,064 | USD | |
| At 2012-03-31 | 18,167,585 | USD | |
| At 2011-12-31 | 19,357,932 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -3,408,448 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -74,394 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -4,043,143 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -1,516,056 | USD | 91 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 763,600 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 205,345 | USD | 91 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 4,528,222 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 6,864,542 | USD | 91 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -1,260 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 554,024 | USD | 91 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -156,197,613 | USD | |
| At 2012-12-31 | -152,789,165 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 126,106,713 | shares | 90 |
| 2012-01-01 to 2012-03-31 | 103,658,571 | shares | 91 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 4,299,655 | USD | |
| At 2012-12-31 | 3,583,104 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 451,276 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 511,716 | USD | 91 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -3,403,289 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -97,059 | USD | 91 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 72,300,558 | USD | |
| At 2012-12-31 | 77,659,232 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 6,396,447 | USD | |
| At 2012-12-31 | 7,938,223 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 3,171,717 | USD | |
| At 2012-12-31 | 2,864,507 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,095,355 | USD | |
| At 2012-12-31 | 1,095,355 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,112,614 | USD | |
| At 2012-12-31 | 1,123,652 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,729,232 | USD | |
| At 2012-12-31 | 2,228,650 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 5,904,368 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 4,970,770 | USD | 91 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 705,813 | USD | |
| At 2012-12-31 | 1,002,703 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 2,501,079 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 4,873,711 | USD | 91 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 2,027,143 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 1,990,831 | USD | 91 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 3,072,685 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 2,877,162 | USD | 91 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 126,170,879 | shares | |
| At 2012-12-31 | 125,949,024 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -684,700 | USD | |
| At 2012-12-31 | -665,345 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 61,050 | USD | |
| At 2012-12-31 | 49,361 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,758,710 | USD | |
| At 2012-12-31 | 2,916,700 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 688,908 | USD | |
| At 2012-12-31 | 463,033 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -3,427,803 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -114,897 | USD | 91 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -3,408,448 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -74,394 | USD | 91 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 1,793,764 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 1,657,541 | USD | 91 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 74,618 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 46,246 | USD | 91 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -5,159 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 22,665 | USD | 91 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -499,418 | USD | 90 |
| 2012-01-01 to 2012-03-31 | -1,126,358 | USD | 91 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -294,873 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 405,722 | USD | 91 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 307,521 | USD | 90 |
| 2012-01-01 to 2012-03-31 | 787,047 | USD | 91 |
Inspect the source
- Entity
- Antares Pharma, Inc. / CIK 0001016169
- Captured
- SEC response SHA-256
540b8a117c7898b4d835a42d9aec42c261c74ea0da49d4755fcc6f2d9b68be71
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001016169.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))